Articles related to Hematology

Although initial animal studies indicated this drug might increase the risk of cancer, current research is showing the opposite. In a large systematic review and meta-analysis, for example, researchers showed that patients who took these drugs before their cancer diagnosis had a 21% lower risk of all-cause mortality and a 31% lower risk of cancer-specific mortality. What is it?

According to several polls (though some said they might change their minds for various reasons), around 4 in 10 Americans have said they will not get a coronavirus vaccine. When it comes to the safety of these vaccines, however, there are good reasons to be confident already. Here are nine explanations to give to a patient, friend, or family member that may be skeptical of the shots.

Investing earlier during your financial trajectory is a good idea: The earlier investments are made, the greater the time value of money. If you are interested in accumulating wealth, it is best to start early and pick some winning strategies. From our friends at MDLinx, here are 10 money moves to consider earlier rather than later.

In June 2020, the US Food and Drug Administration (FDA) granted accelerated approval to tazemetostat (Tazverik, Epizyme), an oral EZH2 inhibitor for the treatment of adult patients with relapsed/refractory follicular lymphoma (FL). Clinical Advances in Hematology & Oncology takes a closer look at this new treatment through a conversation with Dr. Connie Lee Batlevi from MSKCC.

At the 18th Annual 2020 Medical Innovation Summit, experts led by Will Morris, MD, executive medical director for Cleveland Clinic Innovations, and Akhil Saklecha, MD, managing director of Cleveland Clinic Ventures, recognized the top 10 medical advances for 2021. Drum roll, please! Do you agree with the choices?

This article reviews a variety of options that are available to aid in caring for patients who refuse blood transfusions, ranging from tranexamic acid to erythropoiesis-stimulating agents. With the use of these treatments, patients who decline blood transfusion can be safely managed in situations ranging from elective surgery to stem cell transplant to pregnancy.